Search Results 281-290 of 17150 for monoclonal antibody

1. Vedolizumab (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

   Vedolizumab injection is used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is a monoclonal antibody that works on ...

2. Nasopharyngeal Carcinoma Clinical Trials - Mayo Clinic Research

   Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

3. Tislelizumab-jsgr (intravenous route) - Side effects & uses - Mayo Clinic

   Tislelizumab-jsgr is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by ...

4. Covering COVID-19 in 2021 - Mayo Clinic News Network

   Now we have three vaccines in the U.S., and antiviral and monoclonal antibody treatments. That's really incredible." Despite the rapid scientific ...

5. Trastuzumab-dkst (intravenous route) - Side effects & uses - Mayo Clinic

   Trastuzumab-dkst is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...

6. A First-in-Human, Phase 1 Dose-Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BJ-005 in Patients With Advanced Solid Tumor or Lymphoma - Mayo Clinic

   BJ-005 is a recombinant bifunctional molecule, composed of a humanized anti-PD-L1 IgG1 monoclonal antibody (mAb) fused with a portion of the extracellular ...

7. Clinical trials - Oncology (Medical)

   Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

8. Teclistamab-cqyv (subcutaneous route) - Side effects & uses - Mayo Clinic

   These previous treatments include a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. This medicine is available only ...

9. PCSK9 inhibition: A game changer in cholesterol management - Mayo Clinic

   Binding of circulating PCSK9 by parenteral monoclonal antibodies results in augmented recirculation of the LDL receptor to the hepatocyte surface and ...

10. Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...